Wellumio
5 known investors
Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.
AI & Machine LearningDeep TechHealthtechMedical Devices
Founders & leadership
ST
Shieak TzengCo-founder & Co-CEO
SO
Sergei ObruchkovCo-founder & Co-CEO
GB
Gyan BarikExecutive Director, Business Operations & Australia
ZR
Ziad RouagGeneral Manager USA
HM
Harry MarfatiaHead of Finance
DE
David EriksonProgram Manager
Board
SM
Sia MoussaviBoard Chairman
Investors · 5
Frequently asked questions
- What does Wellumio do?
- Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.
- Who founded Wellumio?
- Wellumio was founded by Shieak Tzeng, Sergei Obruchkov.
- Who are Wellumio's investors?
- Wellumio's investors include Booster Innovation Fund, Cure Kids Ventures, Nuance Capital, Outset Ventures, Pacific Channel.